At this point most of you have probably met our new fellows. Gray Jodon (VA), Tyler Friedrich (DH), Frantz Francisque (UCH Onc), and Robert Lentz (UCH Heme) have all settled into our program nicely and are doing an excellent job!
We are well into the swing of recruitment! We have already completed our first two interview dates in September. Our remaining interview day will take place this Friday, October 11. Thank you to everyone for attending the recruitment dinners and lunches, interviewing applicants, and overall being supportive of the fellows and program!
There has been a rumor circulating that we are in the process of a fifth fellow per class. The rumor is true! We are currently working through all the regulatory steps, and hope to add a fifth slot per year with the upcoming match. These additional fellowship slots were made possible by Drs. Jimeno and Jordan's new Immunotherapy T32 (Congratulations!) and Drs. Messersmith and Jordan's leadership.
Jodi Kagihara, MD, has been awarded our first T32 in Immunotherapy!
Hall F, Villalobos V, Wilky B.. Future directions in soft tissue sarcoma treatment. Curr Probl Cancer. 2019 Aug;43(4):300-307. doi: 10.1016/j.currproblcancer.2019.06.004. Epub 2019 Jun 20. Review. PMID: 31229264
Lentz R, Benson AB 3rd, Kircher S. Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies. J Surg Oncol. 2019 Jul;120(1):85-92. PMID: 30650186